| Clinical data | |
|---|---|
| Trade names | Catovit, Katovit, Promotil, Villescon |
| Routes of administration | By mouth,intranasal,rectal |
| Drug class | Stimulant;Norepinephrine–dopamine reuptake inhibitor (NDRI) |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.007.077 |
| Chemical and physical data | |
| Formula | C15H23N |
| Molar mass | 217.356 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 133 °C (271 °F) |
| Boiling point | 153 °C (307 °F) |
| |
| |
| | |
Prolintane is acentral nervous system (CNS)stimulant[2] andnorepinephrine–dopamine reuptake inhibitor (NDRI) of thephenylalkylpyrrolidine family developed in the 1950s.[3] Being anamphetamine derivative, it is closely related inchemical structure to other drugs such aspyrovalerone,MDPV, andpropylhexedrine, and has a similarmechanism of action.[4] Many cases of prolintaneabuse have been reported.[5]
Under the brand nameKatovit, prolintane was commercialized by the Spanish pharmaceutical company FHER until 2001. It was most often used by students and workers as a stimulant to provide energy and increase alertness and concentration.[medical citation needed]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |